Literature DB >> 23541372

Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects.

Shannon M Harlan1, Deng-Fu Guo, Donald A Morgan, Caroline Fernandes-Santos, Kamal Rahmouni.   

Abstract

The fundamental importance of the hypothalamus in the regulation of autonomic and cardiovascular functions is well established. However, the molecular processes involved are not well understood. Here, we show that the mammalian (or mechanistic) target of rapamycin (mTOR) signaling in the hypothalamus is tied to the activity of the sympathetic nervous system and to cardiovascular function. Modulation of mTOR complex 1 (mTORC1) signaling caused dramatic changes in sympathetic traffic, blood flow, and arterial pressure. Our data also demonstrate the importance of hypothalamic mTORC1 signaling in transducing the sympathetic and cardiovascular actions of leptin. Moreover, we show that the PI3K pathway links the leptin receptor to mTORC1 signaling and that changes in its activity impact sympathetic traffic and arterial pressure. These findings establish mTORC1 activity in the hypothalamus as a key determinant of sympathetic and cardiovascular regulation and suggest that dysregulated hypothalamic mTORC1 activity may influence the development of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541372      PMCID: PMC3657313          DOI: 10.1016/j.cmet.2013.02.017

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  38 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

Review 2.  Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions.

Authors:  R A L Dampney; J Horiuchi; S Killinger; M J Sheriff; P S P Tan; L M McDowall
Journal:  Clin Exp Pharmacol Physiol       Date:  2005 May-Jun       Impact factor: 2.557

Review 3.  mTOR, translation initiation and cancer.

Authors:  Y Mamane; E Petroulakis; O LeBacquer; N Sonenberg
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

4.  Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.

Authors:  Lazaros C Foukas; Marc Claret; Wayne Pearce; Klaus Okkenhaug; Stephen Meek; Emma Peskett; Sara Sancho; Andrew J H Smith; Dominic J Withers; Bart Vanhaesebroeck
Journal:  Nature       Date:  2006-04-12       Impact factor: 49.962

5.  Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1.

Authors:  Lifu Wang; Christopher J Rhodes; John C Lawrence
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

Review 6.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

7.  Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin.

Authors:  Kamal Rahmouni; Donald A Morgan
Journal:  Hypertension       Date:  2006-12-26       Impact factor: 10.190

Review 8.  The sympathetic control of blood pressure.

Authors:  Patrice G Guyenet
Journal:  Nat Rev Neurosci       Date:  2006-05       Impact factor: 34.870

9.  Hypothalamic mTOR signaling regulates food intake.

Authors:  Daniela Cota; Karine Proulx; Kathi A Blake Smith; Sara C Kozma; George Thomas; Stephen C Woods; Randy J Seeley
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

Review 10.  Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging.

Authors:  Douglas R Seals; Frank A Dinenno
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11       Impact factor: 4.733

View more
  43 in total

Review 1.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 2.  Leptin signalling pathways in hypothalamic neurons.

Authors:  Obin Kwon; Ki Woo Kim; Min-Seon Kim
Journal:  Cell Mol Life Sci       Date:  2016-01-19       Impact factor: 9.261

Review 3.  Hypothalamic roles of mTOR complex I: integration of nutrient and hormone signals to regulate energy homeostasis.

Authors:  Fang Hu; Yong Xu; Feng Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-10       Impact factor: 4.310

Review 4.  Recent Advances in Neurogenic Hypertension: Dietary Salt, Obesity, and Inflammation.

Authors:  Sean D Stocker; Brian J Kinsman; Alan F Sved
Journal:  Hypertension       Date:  2017-07-24       Impact factor: 10.190

Review 5.  Hypothalamic-autonomic control of energy homeostasis.

Authors:  Patricia Seoane-Collazo; Johan Fernø; Francisco Gonzalez; Carlos Diéguez; Rosaura Leis; Rubén Nogueiras; Miguel López
Journal:  Endocrine       Date:  2015-06-19       Impact factor: 3.633

Review 6.  Cognitive and autonomic determinants of energy homeostasis in obesity.

Authors:  Denis Richard
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

7.  Leptin receptor signaling in the hypothalamus regulates hepatic autonomic nerve activity via phosphatidylinositol 3-kinase and AMP-activated protein kinase.

Authors:  Mamoru Tanida; Naoki Yamamoto; Donald A Morgan; Yasutaka Kurata; Toshishige Shibamoto; Kamal Rahmouni
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

Review 8.  Leptin as a Mediator of Obesity-Induced Hypertension.

Authors:  Balyssa B Bell; Kamal Rahmouni
Journal:  Curr Obes Rep       Date:  2016-12

Review 9.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

10.  Dual action of leptin on rest-firing and stimulated catecholamine release via phosphoinositide 3-kinase-driven BK channel up-regulation in mouse chromaffin cells.

Authors:  Daniela Gavello; David Vandael; Sara Gosso; Emilio Carbone; Valentina Carabelli
Journal:  J Physiol       Date:  2015-09-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.